Document is current
Any future updates will be listed below
-
Authors
Niu, Lili https://orcid.org/0000-0003-4571-4368
Thiele, Maja https://orcid.org/0000-0003-1854-1924
Geyer, Philipp E.
Rasmussen, Ditlev Nytoft
Webel, Henry Emanuel
Santos, Alberto
Gupta, Rajat
Meier, Florian https://orcid.org/0000-0003-4729-175X
Strauss, Maximilian https://orcid.org/0000-0003-3320-6833
Kjaergaard, Maria https://orcid.org/0000-0001-8452-1820
Lindvig, Katrine
Jacobsen, Suganya
Rasmussen, Simon https://orcid.org/0000-0001-6323-9041
Hansen, Torben https://orcid.org/0000-0001-8748-3831
Krag, Aleksander https://orcid.org/0000-0002-9598-4932
Mann, Matthias https://orcid.org/0000-0003-1292-4799
-
Funding
Funding for this research was provided by:
Max-Planck-Gesellschaft
Novo Nordisk Fonden (NNF15CC0001)
Novo Nordisk Fonden (NNF15OC0016692)
Novo Nordisk Fonden (NNF15CC0001)
Novo Nordisk Fonden (NNF16CC0020906)
Novo Nordisk Fonden (NNF15OC0016692)
Novo Nordisk Fonden (NNF14CC0001)
Novo Nordisk Fonden (NNF15OC0016692)
Novo Nordisk Fonden (NNF15OC0016692)
Novo Nordisk Fonden (NNF15OC0016692)
Novo Nordisk Fonden (NNF14CC0001)
Novo Nordisk Fonden (NNF19SA0035440)
Novo Nordisk Fonden (NNF15CC0001)
Novo Nordisk Fonden (NNF15CC0001)
Novo Nordisk Fonden (NNF14CC0001)
EC | Horizon 2020 Framework Programme (668031)
EC | Horizon 2020 Framework Programme (668031)
EC | Horizon 2020 Framework Programme (668031)
EC | Horizon 2020 Framework Programme (668031)
EC | Horizon 2020 Framework Programme (668031)
EC | Horizon 2020 Framework Programme (668031)
EC | Horizon 2020 Framework Programme (668031)
- License Information
-
More Information
Article History
Received: 23 March 2021
Accepted: 28 April 2022
First Online: 2 June 2022
Competing interests
: P.E.G. is a cofounder of OmicEra Diagnostics, a company offering MS-based proteomics analysis, the founding of which was during conduction of the study. M.S. is a former employee at OmicEra Diagnostics. M.M. is currently an indirect investor in Evosep. M.T. has a speaker's fee received from Echosens and Siemens Healthcare. A.K. has served as a speaker for Norgine, Siemens and Nordic Bioscience and has participated in advisory boards for Norgine and Siemens, all outside the submitted work. The remaining authors declare no competing interests.
